• Product NameConivaptan hydrochloride
• Brief DescriptionInhibitors
• Purification99.86%
• Biological ActivityConivaptan HCl is an orally active, non-peptide, vasopressin V1A and V2 receptor antagonist, used in the treatment of euvolemic and hypervolemic hyponatremia.
• Target NameVasopressin Receptor antagonist
• CAS No. 168626-94-6
• Calculated MW 535.04
• Formulation C32H26N4O2HCl
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:Cl.CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1
  Pathways:GPCR/G Protein
  Receptor:vasopressin receptor 1a; vasopressin receptor 2
  Boling pt:
  Melting pt:
  Solubility:Ethanol: 7 mg/mL (13.08 mM); DMSO: 107 mg/mL (199.98 mM)
  Appearance:WhitePowder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Wada K, et al. Eur J Pharmacol, 2005, 507(1-3), 145-151.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting